Project Grant K99AR086337
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $2,058,020 Project Grant to Icahn School of Medicine at Mount Sinai, effective June 1, 2026 through May 31, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds the development and validation of an engineered messenger RNA (mRNA) therapeutic designed to address rotator cuff muscle degeneration. The research will...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Delaware a $666,825 Project Grant on September 1, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to investigate the structural and functional roles of muscle-subtendon units in Achilles tendinopathy. The research will extend through June 30, 2030, utilizing advanced biomechanical sensors, magnetic resonance imaging...
- Federal Project Grant Award Summary The University of Pennsylvania received a $646,506 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 5, 2025, through June 30, 2030. This award supports the development of dual-action nanoparticle-loaded microparticles designed to address osteoarthritis (OA) treatment through an innovative...
- Federal Project Grant Award Summary The University of Texas at San Antonio received a $602,113 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective May 1, 2026 through April 30, 2031. The award supports research into browning of fatty infiltration in rotator cuff tears using novel nanotherapeutics. The research aims to address the challenge of...
- Federal Project Grant Award Summary The University of Pittsburgh received a $147,236 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), with an award date of September 30, 2025, and completion date of May 31, 2028. The project, titled "Quantifying the Mechanical Effects of Knee Bracing and Predicting Their Ability to Prevent Ligamentous Injury,"...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded the University of Pennsylvania a $857,127 Project Grant on June 3, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to investigate mitochondrial respiration and growth plate chondrocyte biology. The research project, extending through April 30, 2030, examines how bioenergetic metabolism—specifically glycolysis and oxidative phosphorylation...
- Federal Grant Award Summary The University of Pennsylvania received a $546,145 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective May 1, 2026 through March 31, 2031. This research initiative delivers scientific investigation into the molecular mechanisms of telomere function in muscle cells, specifically examining how telomere-associated...
- Federal Grant Award Summary The University of Pennsylvania received a $507,738 project grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded July 25, 2025, with a completion date of May 31, 2030. This grant funds research and development of a Tension-Activated Annular Repair Scaffold (TARS)—a novel biomedical device designed to repair annulus fibrosus (AF) defects...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded President and Fellows of Harvard College a $676,841 project grant effective August 1, 2025, through July 31, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The project, "Leveraging Human Musculoskeletal Development to Identify Causal Disease Variants," will deliver comprehensive transcriptomic and epigenomic mapping of human...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $243,192 Project Grant to Massachusetts General Hospital (MGH), effective November 1, 2025 through April 30, 2028, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research project investigates the role of Wnt signaling in the mechanical maturation of tendon, with the primary objective of elucidating cellular and molecular...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Trustees of The University of Pennsylvania a $100,331 Project Grant (CFDA 93.846: Arthritis, Musculoskeletal and Skin Diseases Research) effective May 5, 2026, through April 30, 2028. This research project investigates the roles of real-world shoulder biomechanics in rotator cuff tendinopathy rehabilitation. The research addresses the high non-response rate to physical therapy (PT) treatment by examining how in-clinic therapeutic gains translate—or fail to translate—to improved real-world shoulder mechanics during activities of daily living. The project delivers research findings through two coordinated aims: a cross-sectional study (K99 phase) that utilizes wearable sensors to track bilateral shoulder motion over seven days, applies motion analysis and musculoskeletal modeling to identify pathomechanics specific to functional daily tasks, and employs machine learning to quantify real-world cumulative rotator cuff tendon loading; and a longitudinal cohort study (R00 phase) that links real-world biomechanics with clinical outcomes including pain, shoulder function, and tendon structure through a three-month PT protocol. This research is expected to provide validated tools and evidence clarifying how patient shoulder motion and tendon loading deviate from normal status, ultimately improving understanding of pain recurrence and rehabilitation outcomes in rotator cuff tendinopathy.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $100.3k | 5/7/26 |